| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 193 | 821 | 609 | 495 | | Selling General and Administrative | 144 | 436 | 381 | 631 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (337) | (1,257) | (990) | (1,125) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 0 | 2 | 7 | | Earnings Before Interest And Taxes | (337) | (1,257) | (987) | (1,118) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (337) | (1,257) | (987) | (1,118) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (337) | (1,257) | (987) | (1,118) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (337) | (1,257) | (987) | (1,118) | | Preferred Stock And Other Adjustments | (3,023) |
-
|
-
| (3,097) | | | Net Income Applicable To Common Shares | ($3,361) | ($1,257) | ($987) | ($4,215) |
|
0.51% Nasdaq 
Income Statement
